Listen now (14 min) | The FDA has granted the plasma NFL assay Breakthrough Device designation as a prognostic aid in assessing patients with relapsing-remitting MS. What does this mean for me?
0 subscriptions will be displayed on your profile (edit)
Skip for now
For your security, we need to re-authenticate you.
Click the link we sent to , or click here to sign in.